Latest Conference Articles

Physicians can now more accurately recognize concussions in athletes by using an advanced form of ultrasound.

Cirrhosis is not a new condition in the medical community, but researchers are looking at regions where the condition may be more common and how changes in policy regarding alcohol could help prevent more cases of the condition in the future.

While many forms of hepatitis C are now nearing curability, there are some genotypes which are harder to treat and some patient populations proving harder to reach. Research is being done on several fronts to address both issues.

Clemastine fumarate, an over-the-counter drug used to fight allergies, can also treat vision damage in patients with multiple sclerosis (MS).

Patients with fatty liver disease are at higher risk of dying if they have a high aspartate aminotransferase to platelet ratio index (APRI), federal researchers in the US report.

In patients with non-alcoholic fatty liver disease, fat tissue insulin resistance can stimulate the activation of hepatic macrophages, due to an increased flux of free fatty acids. That results in liver damage, Italian researchers report.

Researchers in France have devised a way to reproduce liver fibrogenesis related to HCV infection, or exposure to ethanol of lipids.

A multi-national workplace fitness event got workers out of their chairs by racing around the globe, virtually.

Even as technology improves to help patients dealing with cardiovascular disease, those responsible for the procedures also must consider providing treatment while weighing the costs of that work.

Since its inception nearly a decade ago the PARTNER trials have shown new opportunities for cardiovascular disease patients to receive treatment they may not have been candidates for before.

An experiment in which paramedics gave heart attack patients antiarrythmic drugs before they arrived at a hospital had disappointing results.

Can “Chest Pain Choice†an informative chart designed to guide emergency patients in making treatment decisions make a difference in care, patient anxiety, and costs? Mayo Clinic doctors say it did in their study.

For a chronic condition like heart failure there are many factors that can help decide the effectiveness of their care. A recent debate looked at whether low salt diet would help in that effort.

As doctors have more tools to treat patients with high cholesterol the American College of Cardiology released a new consensus statement to give guidance on potential best practices for non-statin therapies like PCSK9 inhibitors.

Even the most seasoned medical research teams can find themselves not reaching the goals they set out for themselves in a study. Learning from those lessons can sometimes be more motivation to find answers down the road.

With statins being a common treatment option for high cholesterol and PCSK9 inhibitors gaining traction since their approval in the past year research has looked at just how low a person's LDL, or bad cholesterol can go.

At the 2015 meeting of the American College of Cardiology PCSK9 inhibitors like Praluent were moving closer to approval but were not there yet. Since then they have been approved and begun to be introduced to the public.

The American College of Cardiology's outgoing President Kim A. Williams, MD, went vegan in 2003 and never looked back. He talks about the diet's power to heal and how being the ACC's first vegan leader played out.

How a doctor presents themselves on social media can determine how effective it is in getting their message across while also maintaining a safe barrier between them and their patients.

Social media platforms like Facebook and Twitter may be regularly used by patients but some doctors have been slower to incorporate these tools into their practice.

As Xarelto is used in practice by more doctors researchers at Janssen Pharmaceuticals are getting a better sense of its efficacy beyond the extensive clinical trials it underwent.

As one of the components of the CHADS2 score diabetes is a known risk for stroke. A recent study looked at how rivaroxaban, also known as Xarelto can help patients reduce this potentially deadly health issue.

An electronic device that stimulates the vagus nerve improved patients’ ability to walk farther without getting winded and was proven to be safe, but it did not affect rates of death or hospitalization, researchers found.

Stem cell treatment did 37% better than placebo treatment in a group of patients with ischemic heart failure.

Adding aliskiren to enalapril in treating heart failure patients resulted in more adverse events but no benefit, a UK team reported.

For those how enter the field of genetic testing there are many challenges along the way, starting with finding the right training program through using that training in very difficult situations.

As more is learned about genetic conditions in cardiology more is being done to help not only to help the patients themselves but those around them as well.

Hopes that losmapimod would benefit patients after a STEMI heart attack were not borne out by a study reported today at the American College of Cardiology's meeting in Chicago, IL.

The search for a drug to prevent kidney injuries from contrast media used in coronary angiography goes on. Trials of a new drug were disappointing.